REPEAT: Seeing Machines loss narrows; Hansard profit falls
25th Sep 2025 15:04
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 74.00p on 18-11-2025 at 19:00:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 78.00p |
| Sell | 70.00p |
| Last Trade: | Unknown 20,000.00 at 74.25p |
| Day's Volume: | 144,484 |
| Last Close: | 74.00p |
| Open: | 74.00p |
| ISIN: | GB00BMWLM973 |
| Day's Range | 74.00p - 74.00p |
| 52wk Range: | 35.40p - 97.50p |
| Market Capitalisation: | £27.94m |
| VWAP: | 74.70865p |
| Shares in Issue: | 37.76m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Arecor Therape (AREC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 20,000 | 74.25p | Negotiated Trade |
16:40:39 - 18-Nov-25 |
| Unknown* | 10,000 | 75.40p | Ordinary |
16:26:05 - 18-Nov-25 |
| Unknown* | 20,000 | 75.00p | Negotiated Trade |
13:09:16 - 18-Nov-25 |
| Sell* | 6,582 | 73.50p | Ordinary |
12:53:10 - 18-Nov-25 |
| Unknown* | 25,000 | 73.50p | Negotiated Trade |
12:53:09 - 18-Nov-25 |
| Buy* | 35,000 | 75.15p | Suspected BUY Trade |
12:46:06 - 18-Nov-25 |
| Buy* | 6,631 | 75.40p | Ordinary |
11:52:25 - 18-Nov-25 |
| Buy* | 1,320 | 75.40p | Ordinary |
11:49:00 - 18-Nov-25 |
| Sell* | 8 | 70.00p | SI Trade |
11:44:53 - 18-Nov-25 |
| Unknown* | 19,893 | 75.40p | Negotiated Trade |
11:15:46 - 18-Nov-25 |
Arecor Therape (AREC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Nov 2025 11:37 am | RNS | Holding(s) in Company |
| 11th Nov 2025 9:50 am | RNS | Holding(s) in Company |
| 4th Nov 2025 7:00 am | RNS | Enhanced IP Coverage: AT278 & Oral Peptide Program |
| 29th Sep 2025 7:00 am | RNS | Directorate Changes |
| 25th Sep 2025 7:00 am | RNS | Interim results for the six months to 30 June 2025 |
| 25th Sep 2025 7:00 am | RNS | Co-Development Agreement & Monetisation Deal |
| 24th Sep 2025 9:30 am | RNS | Notice of Interim Results |
| 4th Sep 2025 7:00 am | RNS | Positive FDA Feedback on Phase 2 Study Design |
| 28th Aug 2025 12:00 pm | RNS | Holding(s) in Company |
| 8th Aug 2025 7:00 am | RNS | Change of Auditor |